VC  Bio-Star Ventures

     Office Locations:

560 W. Mitchell Street, Suite 500
Petoskey, MI 49770
Phone: 231-487-9186
Fax: 231-487-9183



  • Early
  • Expansion
  • Growth
  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    BioStar Ventures is a venture capital partnership formed in 2003 by physicians and medical business leaders to invest primarily in early-stage medical devices. BioStar prefers to invest in the cardiovascular, orthopedic, neuroscience, and gastroenterology clinical specialties, but the partners are also interested in looking at biomaterials and how they can be used in any type of clinical area. If appropriate, BioStar will serve as lead investor but will participate in follow on investments as well. The firm's initial investment in a company ranges from $250K - $3 million, depending on the technology and stage of a company's development. BioStar intends to support portfolio companies in their follow-on financing rounds through time of exit. Accordingly, BioStar invests between $2 - $6 million over the life of an investment. BioStar invests in companies throughout the United States and has offices in Michigan, Philadelphia, and California.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    David J. Brophy PhD Director
    Jim Bennethum Director
    Louis A. Cannon MD Founder and Senior Managing Director
    Paul A. Scott Chief Financial Officer and Managing Director
    Renee Masi Managing Director


    Portfolio companies include:

      Ablative Solutions
        web link

      Angioslide Ltd.
        web link

        web link

      Aria CV, Inc.
        web link

        web link

      Autonomix Medical, Inc.
        web link

      Avantis Medical Systems
        web link

      Axis Surgical Technologies

      Bioabsorbable Therapeutics
        web link

      Broncus Technologies
        web link

        web link

      Conventus Orthopaedics, Inc.
        web link

      Corindus Vascular Robotics, Inc.
        web link

      CV Ingenuity
        web link

        web link

      Domain Surgical
        web link

      Ellipse Technologies
        web link

      Embrella Cardiovascular
        web link

      Guided Delivery Systems
        web link

      Hotspur Technologies
        web link

      Interventional Spine
        web link

      Kona Medical
        web link

        web link

      NanoMed Systems
        web link

      Nellix Endovascular
        web link

      NewPace Ltd.
        web link

      OmniGuide, Inc.
        web link

      Onset Medical
        web link

        web link

      Phoenix Biomedical
        web link

      Revascular Therapeutics
        web link

      Reverse Medical

        web link

        web link

      TransMedics, Inc.
        web link

      Trice Orthopedics
        web link

      TriVentures II Fund
        web link

      V-Wave Ltd.
        web link

      VytronUS, Inc.
        web link


    Recent News:

      There is no recent news for Bio-Star Ventures.